The global tissue sectioning market size is expected to reach USD 1,145.3 million by 2033, registering a CAGR of 6.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. A rise in prevalence of cancer coupled with the awareness among physicians regarding the use of tissue diagnostic procedures for prognostication and diagnostics is expected to fuel the growth.
As per the NIH-National Cancer Institute, the number of new cancer cases is expected to rise to 23.6 million by 2030. Germany ranks in the top 5 countries that have super-aged societies. It is expected that one-third of the total population of Germany will be above 65 year of age by 2050. This increases the change of encountering cancer, liver and kidney disorders, autoimmune diseases, and infections.
As the analysis of tissue sections is helpful in the management and identification of clinical disorders, thus a rise in the geriatric population leads to a rise in demand for tissue sectioning equipment for effective and rapid tissue diagnostics. In addition, shifting focus of the researchers and pathologists toward exploring the cancer staging in rare types of cancer is anticipated to boost the market growth in the forthcoming years.
A rise in the number of histology laboratories globally is a key driving factor for the market. In addition, constant rise in the number of certified pathologists in Canada and other major countries is expected to support the projected growth of the market. These laboratories are adopting novel protocols that aid in troubleshooting the challenges associated with tissue processing.
Request a free sample copy or view report summary: Tissue Sectioning Market Report
Instruments accounted for the largest market share in 2025 owing to the presence of a substantial commercially available product base, ongoing technological advancements, and lack of any external substitute for tissue sectioning equipment
Rotary microtome is the most-commonly used microtomes in a histopathology lab, thereby leading to its prominent revenue share
Automatic technology is expected to occupy substantial share of the technology segment in 2025 as these products enable cutting of thin tissue sectioning with a high precision consistently
Automated devices also enhance productivity by enhancing the speed and efficiency of the process. These devices are user-friendly as they reduce the need for repetitive motion of the microtome
Disease diagnosis dominated the applications segment in 2025 owing to a rise in adoption of histopathology techniques for the diagnosis of cancer and other disorders
An accurate pathology analysis is crucial for the diagnosis and determination of a treatment plan for patients. This increases the utilization of microtomes and cryostats in histopathology laboratories for disease diagnosis
Hospitals end-user segment is projected to continue holding the largest market share during the forecast period, as hospitals are the key facilities for the analysis of tissue specimen
Presence of a large number of hospitals with in-house pathology laboratories for analysis of biopsy specimen is expected to boost the segment growth
North America held the largest share of the tissue sectioning market in 2025. Asia Pacific, on the other hand, is expected to register the fastest CAGR in the forthcoming years
Some key market players include Thermo Fisher Scientific, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, and Sakura Finetek Europe B.V.
Grand View Research has segmented the global tissue sectioning market based on product, technology, application, end use, and region:
Tissue Sectioning Product Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Rotary Microtomes
Cryostats
Ultramicrotomes
Vibratomes
Others
Accessories & Consumables
Blades & Knives
Cryo-Embedding Media
Specimen Holders & Chucks
Others
Services
Tissue Sectioning Technology Outlook (Revenue, USD Million, 2021 - 2033)
Fully Automated
Semi-Automated
Manual
Tissue Sectioning Application Outlook (Revenue, USD Million, 2021 - 2033)
Disease Diagnosis
Research
Drug Discovery & Preclinical Toxicology
Others
Tissue Sectioning End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Diagnostic & Pathology Laboratories
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies and CROs
Others
Tissue Sectioning Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
Saudi Arabia
South Africa
UAE
Kuwait
List Of Key Players in the Tissue Sectioning Market
Danaher Corporation (Leica Biosystems)
PHC Holdings Corporation (Epredia)
Sakura Finetek Japan Co., Ltd.
StatLab Medical Products (Diapath S.p.A.)
MEDITE Medical GmbH
SLEE medical GmbH
Amos Scientific Pty. Ltd.
Bright Instruments Ltd.
Boeckeler Instruments, Inc.
Precisionary Instruments LLC
Diatome AG
RWD Life Science Co., Ltd.
Histo-Line Laboratories S.r.l.
Clarapath, Inc.
Charles River Laboratories International, Inc.
"The quality of research they have done for us has been excellent..."